INVESTMENTS MEASURED AT FAIR VALUE (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Investments [Line Items]

SCHEDULE OF FINANCIAL ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS

Financial assets measured at fair value on a recurring basis are summarized below and disclosed on the consolidated balance sheets as of December 31, 2025 and 2024:

	Fair Value Measurement Using						Amount at
	Level 1		Level 2		Level 3		Fair Value
December 31, 2025
Assets
Investment Securities at Fair Value - Related Parties	$	3,683,925	$	48,115	$	-	$	3,732,040
Investment Securities at Fair Value - Third Parties		14,264,655		418,605		-		14,683,260
Warrants - HIPH		-		-		973		973
Warrants - VEII		-		18,301		-		18,301
Warrants - SHRG		-		87		-		87
Convertible Note Receivable - VEII		-		517,275		-		517,275
Convertible Note Receivable - SHRG		-		1,736,829		-		1,736,829
Total Investment in Securities at Fair Value	$	17,948,580	$	2,739,211	$	973	$	20,688,764

	Fair Value Measurement Using						Amount at
	Level 1		Level 2		Level 3		Fair Value
December 31, 2024
Assets
Investment Securities at Fair Value - Related Parties	$	3,565,089	$	7,463,324	$	-	$	11,028,413
Investment Securities at Fair Value - Third Parties		2,612,293		2,061,230		-		4,673,523
Warrants - HIPH		-		-		973		973
Warrants - VEII		-		1,299,973		-		1,299,973
Warrants - SHRG		-		13,272		-		13,272
Convertible Note Receivable - VEII		-		569,630		-		569,630
Convertible Note Receivable - SHRG		-		1,212,746		-		1,212,746
Total Investment in Securities at Fair Value	$	6,177,382	$	12,620,175	$	973	$	18,798,530

SCHEDULE OF FAIR VALUE OF EQUITY SECURITY INVESTMENT

The following chart shows details of the fair value of equity security investment at December 31, 2025 and December 31, 2024, respectively.

	Share price				Market Value
	12/31/2025		Shares		12/31/2025		Valuation

DSS (Related Party)	$	0.930		3,961,210	$	3,683,925	Investment in Securities at Fair Value

Investment Securities at Fair Value - Third Parties					$	14,264,655	Investment in Securities at Fair Value

		Total Level 1 Equity Securities			$	17,948,580

Holista	$	0.057		1,000	$	57	Investment in Securities at Fair Value

HIPH World (Related Party)	$	0.000		354,039,000	$	35,404	Investment in Securities at Fair Value

AMBS	$	0.000		20,000,000	$	0	Investment in Securities at Fair Value

Value Exchange (Related Party)	$	0.001		21,179,275	$	10,590	Investment in Securities at Fair Value

Sharing Services (Related Party)	$	0.023		89,732	$	2,064	Investment in Securities at Fair Value

Investment Securities at Fair Value - Third Parties					$	418,605	Investment in Securities at Fair Value

		Total Level 2 Equity Securities			$	466,720
Nervotec		N/A		1,666	$	0	Investment in Securities at Cost
K Beauty		N/A		3,600	$	16,696	Investment in Securities at Cost
Ideal Food and Beverages		N/A		19,000	$	0	Investment in Securities at Cost
HapiTravel Holding		N/A		19,000	$	148	Investment in Securities at Cost
AES Group Co. Ltd.		N/A		398	$	1,382	Investment in Securities at Cost

		Total Equity Securities			$	18,433,526

	Share price				Market Value
	12/31/2024		Shares		12/31/2024		Valuation

DSS (Related Party)	$	0.900		3,961,210	$	3,565,089	Investment in Securities at Fair Value

Trading Stock					$	2,612,293	Investment in Securities at Fair Value

		Total Level 1 Equity Securities			$	6,177,382

Holista	$	0.008		1,000	$	8	Investment in Securities at Fair Value

New Electric CV (Related Party)	$	0.000		354,039,000	$	0	Investment in Securities at Fair Value

AMBS	$	0.000		20,000,000	$	0	Investment in Securities at Fair Value

Value Exchange (related Party)	$	0.035		21,179,275	$	749,746	Investment in Securities at Fair Value

Sharing Services (Related Party)	$	1.000		89,732	$	89,732	Investment in Securities at Fair Value

Impact BioMedical (Related Party)	$	1.450		4,568,165	$	6,623,838	Investment in Securities at Fair Value

Trading Stock					$	2,061,230	Investment in Securities at Fair Value

		Total Level 2 Equity Securities			$	9,524,554
Nervotec		N/A		1,666	$	589	Investment in Securities at Cost
K Beauty		N/A		3,600	$	16,733	Investment in Securities at Cost
Ideal Food and Beverages		N/A		19,000	$	0	Investment in Securities at Cost
HapiTravel Holding		N/A		19,000	$	140	Investment in Securities at Cost

		Total Equity Securities			$	15,719,398

SCHEDULE OF SUMMARIZED UNAUDITED FINANCIAL INFORMATION OF EQUITY METHOD INVESTMENTS

The following table presents summarized unaudited financial information for our investments that we elected the fair value option that would otherwise be accounted for under the equity method of accounting.

	Summarized Financial Information
	Assets		Liabilities		Net Loss
December 31, 2025
HIPH	$	12,627,000	$	2,218,000	$	(361,000	)
DSS*	$	92,123,000	$	66,015,000	$	(13,449,000	)
VEII**	$	6,844,729	$	10,744,581	$	(640,853	)
SHRG***	$	6,257,230	$	10,470,791	$	(2,869,424	)

December 31, 2024
HIPH	$	12,684,000	$	2,254,000	$	(283,000	)
DSS	$	106,453,000	$	73,737,000	$	(53,706,000	)
VEII**	$	6,844,729	$	10,744,581	$	(640,853	)
SHRG***	$	6,257,230	$	10,470,791	$	(2,869,424	)

*	Data derived from Financial Statement as of September 30, 2025, which was the latest available date source we could reach. 12-month Net Loss was estimated by adding one-third of 9-month Net Loss.
**	Data derived from Financial Statement as of September 30, 2024, which was the latest available date source we could reach. 12-month Net Loss was estimated by adding one-third of 9-month Net Loss.
***	Data derived from Financial Statement as of September 30, 2024, which was the latest available date source we could reach. 12-month Net Loss was estimated by doubling the 6-month Net Loss.

Sharing Services Convertible Note [Member]

Schedule of Investments [Line Items]

SCHEDULE OF CHANGE IN FAIR VALUE

The table below provides a summary of the changes in fair value which are recorded through other income (loss), including net transfers in and/or out of all financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the years ended December 31, 2025 and 2024:

SCHEDULE OF CHANGE IN FAIR VALUE

	Total
Balance at January 1, 2024	$	77,737
Impairment		(77,307	)
Net loss		543
Balance at December 31, 2024	$	973
Net gain		-
Net gain		-
Balance at December 31, 2025	$	973

HIPH World Inc. [Member]

Schedule of Investments [Line Items]

SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS

The fair value of the HIPH warrants under level 3 category as of December 31, 2025 and 2024 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:

	December 31, 2025			December 31, 2024
Stock Price	$	0.0001		$	0.0001
Exercise Price	$	0.001		$	0.001
Risk-free Interest Rate		4.62	%		4.62	%
Annualized volatility		869.4	%		869.4	%
Dividend Yield		0.00			0.00
Year to Maturity		4.56			5.56

VEII Warrants [Member]

Schedule of Investments [Line Items]

SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS

The fair value of the VEII warrants under level 3 category as of December 31, 2025 and 2024 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:

	December 31, 2025			December 31, 2024
Stock Price	$	0.0005		$	0.0354
Exercise Price	$	0.1770		$	0.1770
Risk-free Interest Rate		6.75	%		7.50	%
Annualized volatility		446.80	%		458.92	%
Dividend Yield		0.00			0.00
Year to Maturity		2.68			3.68

SHRG Warrants [Member]

Schedule of Investments [Line Items]

SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS

The fair value of the SHRG warrants under level 2 category as of December 31, 2025, was calculated using binomial option pricing model valued with the following weighted average assumptions:

	December 31, 2025			December 31, 2024
Stock Price	$	0.0230		$	1.0000
Exercise Price	$	1.6800		$	1.6800
Risk-free Interest Rate		3.56	%		4.34	%
Annualized volatility		390.99	%		204.14	%
Dividend Yield		0.00			0.00
Year to Maturity		3.21			4.21

SHRG Warrants Two [Member]

Schedule of Investments [Line Items]

SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS

	December 31, 2025
Stock Price	$	0.0230
Exercise Price	$	0.8500
Risk-free Interest Rate		3.49	%
Annualized volatility		390.99	%
Dividend Yield		0.00
Year to Maturity		2.25

Alset Inc. 10-K